1-4 of 4
Ronald H. Lands, MD
Close
Sort by
Journal Articles

Detection of Systemic AL Amyloidosis and Differentiation of AL from Attr Using 124 I-p5+14 PET Imaging

Jonathan S. Wall, PhD, R. Eric Heidel, PhD, Alan Stuckey, Emily B. Martin, PhD, Tina Richey, MS, Angela Williams, MS, James S. Foster, MS, Bryan Whittle, Yitong Fu, MD, Dustin Powell, MD, Ronald H. Lands, MD, Spencer Guthrie, Stephen J. Kennel, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-143307
Published: 2020
Journal Articles

Preliminary Phase 1 Data on the Safety and Efficacy of a Novel PET Radiotracer, 124 I-p5+14, for Imaging Systemic Amyloidosis

Jonathan S. Wall, PhD, Alan Stuckey, Emily B. Martin, PhD, Tina Richey, MS, Angela Williams, MS, Daniel Craig Wooliver, Sallie Macy, James S. Foster, MS, Bryan Whittle, Robin Geldrich, Mark Powell, Yitong Fu, MD, Dustin Powell, MD, Dustin Osborne, PhD, R. Eric Heidel, PhD, Barbara Marine, Myrwood Besozzi, MD, Radhakrishnan Ramchandren, MD, Ronald H. Lands, MD, Stephen J. Kennel, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3034.
https://doi.org/10.1182/blood-2019-128850
Published: 2019
Journal Articles

Initial Report of a Serum Assay to Predict Amyloid Risk in Patients with Multiple Myeloma or Monoclonal Gammopathy of Undetermined Significance

Emily B. Martin, PhD, Angela Williams, MS, R. Eric Heidel, PhD, Ronald H. Lands, MD, Stephen J. Kennel, PhD, Angela Dispenzieri, MD, Jonathan S. Wall, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5371.
https://doi.org/10.1182/blood.V130.Suppl_1.5371.5371
Published: 2017
Journal Articles

A Method to Identify Patients with Multiple Myeloma Who Are at Risk of Developing Concomitant Amyloidosis

Emily B. Martin, PhD, Angela Williams, MS, R. Eric Heidel, PhD, Ronald H. Lands, MD, Stephen J. Kennel, PhD, Jonathan S. Wall, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4339.
https://doi.org/10.1182/blood.V130.Suppl_1.4339.4339
Published: 2017